1 Hour CE/CME — Live Case Rounds
Fatty Liver Case Rounds
Real-World Treatment Plans That Work
Stop second-guessing fatty liver workups. Walk through real cases with a stepwise framework you can use next Monday — from risk stratification to treatment to monitoring.
1 hr
CME/CE Credit
3
Real Patient Cases
Live
& On-Demand Options
∞
Lifetime Access
April 24 at 12 pm EST • Money-back guarantee • Instant access after live event
Fatty Liver Is the Metabolic Canary
“Enzymes look okay — must be fine.” Sound familiar? That assumption is silently advancing liver disease in your patients right now.
What You’re Seeing Now
✕
- Normal ALT/AST → chart closed, risk missed
- Ultrasound “fatty liver” noted, no follow-up plan
- Metabolic syndrome progressing under the surface
- Unsure when to escalate, refer, or intervene
After This Course
✓
- Catch high-risk patients even with “normal” enzymes
- Use FIB-4 and fibrosis tools to stratify urgency
- Apply a stepwise treatment ladder you can repeat
- Know exactly when to refer and what to start now
After 60 Minutes, You’ll Be Able To
Four clinical competencies you can apply immediately:
Identify Hidden Risk
Spot MAFLD/MASH patterns even with normal liver enzymes
Interpret Key Markers
Use FIB-4, GGT, TG/HDL ratio, and fibrosis tools with confidence
Apply a Treatment Ladder
Stepwise framework from lifestyle to pharmacotherapy to nutraceuticals
Build a Monitoring Plan
Labs, imaging, follow-up intervals, and when to refer
Why This Course Was Created
“Fatty liver disease is the most common liver condition on the planet — yet most providers were never taught how to evaluate it, stage it, or treat it. We chart ‘fatty liver on ultrasound,’ close the note, and move on.
Meanwhile, MAFLD is silently progressing in patients with prediabetes, central adiposity, and metabolic syndrome — even when their liver enzymes look ‘normal.’
This course gives you a repeatable framework — built around real patient cases — so you can catch risk earlier, intervene smarter, and know exactly when to escalate.”
Who This Is For
Built for Cardiometabolic & Primary Care Clinicians
No hepatology fellowship required. Just the practical tools to manage fatty liver with the patients you’re already seeing.
Pharmacists
Expanding metabolic health knowledge
NPs & PAs
Managing metabolic patients in primary care
Physicians
Family medicine, internal medicine, cardiometabolic
Nurses & RDs
Supporting metabolic and liver health interventions
Clinicians New to Metabolic Liver Disease
Wanting a structured approach, not GI overwhelm
Anyone Managing Metabolic Syndrome
Who wants to address the liver piece they’ve been skipping
How This Course Is Different
Not a Hepatology Lecture
This is case-based, clinically grounded, and designed for the patients you’re already seeing.
Case-Based
Learn through real patient scenarios, not slides full of pathology
Actionable
Walk away with a repeatable treatment ladder for your next clinic day
Evidence-Informed
Integrates lifestyle, pharmacotherapy, and nutraceuticals where the data supports it
Complete Curriculum
What You’ll Cover in 60 Minutes
A structured walkthrough from recognition to treatment to monitoring — built around real patient cases.
1
Why Fatty Liver Is “The Metabolic Canary”
MAFLD/MASH as the liver expression of insulin resistance, visceral adiposity, and inflammation — and why “enzymes look okay” is not the same as “liver is fine”
2
Markers That Matter — What to Order & How to Interpret
ALT/AST patterns, GGT, platelets, fasting insulin, A1c, TG/HDL ratio, hs-CRP — plus FIB-4, NAFLD Fibrosis Score, and when to escalate to elastography or hepatology referral
3
Case 1: “Normal Enzymes, High Risk”
Prediabetic patient with central adiposity, fatigue, and high triglycerides — walkthrough from initial work-up to fibrosis risk tool to initial interventions and monitoring plan
4
Case 2: “Diabetes + Rising ALT + Ultrasound Fatty Liver”
T2D patient on standard meds with weight plateau and possible MASH risk — pharmacotherapy decision-making including GLP-1/GIP agents, gut/metabolic inflammation drivers, dietary levers, protein and resistance training
5
Case 3: “Advanced Risk / Fibrosis Concern”
Metabolic syndrome patient with low platelets or high FIB-4 — urgent flags, referral timing, and what can still be initiated safely while awaiting specialist
6
The Liver Recovery Ladder — A Repeatable Treatment Framework
Remove biggest drivers → Restore metabolic flexibility → Pharmacotherapy toolset (including GLP-1 data on MAFLD) → Targeted nutraceutical support → Monitoring cadence and reassessment checkpoints
You’ll Walk Away With
A stepwise treatment ladder you can repeat with every patient
Confidence interpreting liver markers and fibrosis risk tools
Clear criteria for when to refer vs. when to start treatment
A monitoring cadence with labs, imaging, and follow-up intervals
Course Format
Flexible Learning Options
Live Session
- April 24, 2026 at 12:00 pm EST
- Live Q&A with the instructor
- All clinicians welcome to participate
- Live CE credit available for pharmacists
On-Demand
- 1 hour CE/CME credit available
- For pharmacists, NPs, nurses, PAs, physicians, and RDs
- Lifetime access — learn at your own pace
- Recording available after live event
Your Instructor
Meet Your Speaker
Yousef Elyaman, MD, IFMCP
IFM Teaching Faculty • Integrative & Functional Medicine
Dr. Elyaman is the founder and Medical Director of Absolute Health Medical Wellness Center in Ocala, Florida, and serves as the Integrative & Functional Medicine Director at The Guest House, a trauma and substance abuse treatment facility. He is a teaching faculty member at The Institute for Functional Medicine, where he leads advanced practice modules.
Board certified in both Internal Medicine and Integrative Medicine, Dr. Elyaman was one of the first graduates of IFM’s certification program (IFMCP, 2014) and has practiced medicine for nearly two decades. He also leads the Functional Medicine Practitioners Forum, one of the most widely engaged clinician communities in functional medicine.
Board Certified, Internal Medicine
Board Certified, Integrative Medicine
IFM Teaching Faculty
Frequently Asked Questions
Who is eligible for CE/CME credit?
This course offers 1 CE/CME credit for physicians, nurse practitioners, physician assistants, pharmacists, registered nurses, and registered dietitians. Credits are provided through our accredited continuing education partner.
Do I need prior hepatology or GI training?
Not at all. This course is designed for primary care and cardiometabolic clinicians who encounter fatty liver in everyday practice. Everything is explained in practical, clinically relevant terms — no GI fellowship required.
What is the “Liver Recovery Ladder”?
It’s a simple, repeatable 5-step treatment framework you can apply immediately: (1) Remove biggest drivers, (2) Restore metabolic flexibility, (3) Pharmacotherapy where appropriate, (4) Targeted nutraceutical support when data supports it, (5) Monitoring cadence and reassessment checkpoints.
How long will I have access?
You’ll have lifetime access to the on-demand course materials. Watch as many times as you need, whenever you need a refresher.
What if I can’t make the live session on April 24?
No problem! The live session is recorded and made available on-demand within 24 hours. You’ll have full access to the recording with your enrollment.
Stop Charting “Fatty Liver” and Closing the Note
Get a repeatable framework to evaluate, treat, and monitor fatty liver disease — starting with your next patient.
1 Hour CE/CME
Lifetime access • Live April 24 & on-demand • 3 real patient cases • The Liver Recovery Ladder
AKH Inc is an accredited provider through Joint Accreditation. AKH and Revelar Health LLC are jointly providing credit for this activity. It will be awarded AMA PRA Category 1 Credit(s)™, ACPE, AAPA, AANP, and ANCC credit. Full CE/CME details can be found here.